MPH

THE PROSTATE CANCER FOUNDATION ANNOUNCES 2023 CHALLENGE AWARDS TOTALING MORE THAN $21 MILLION FOR PROSTATE CANCER RESEARCH

Retrieved on: 
Thursday, March 14, 2024
University of Illinois Urbana-Champaign, PCF, University of Sydney, Prostate cancer, Genetic testing, Immunotherapy, Prostate Cancer Foundation, Lund University, Oncogene, Patient, PET, Biomarker, Research, Aircraft pilot, University, Doctor of Philosophy, Biology, MBA, MPH, Johns Hopkins University, Institute of Cancer Research, CBP, University of Pretoria, PSMA, Medical imaging

LOS ANGELES, March 14, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research.

Key Points: 
  • LOS ANGELES, March 14, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research.
  • PCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly innovative research with the greatest potential for accelerating new and improved treatments for advanced prostate cancer.
  • Following a rigorous peer review process that assessed each project's scientific merit and potential patient impact, 20 highly coveted PCF Challenge Awards totaling $21.3 million were granted to teams at some of the world's leading cancer research institutions.
  • (Evaluating the impact of treatment with darolutamide on age-related outcomes in vulnerable, older patients with metastatic hormone-sensitive prostate cancer.)

Diagnostics Direct, LLC Announces Formation of a Medical Advisory Board

Retrieved on: 
Wednesday, March 13, 2024
Diagnosis, Attention, Advisory board, Public health, Entrepreneurship, Syphilis, Patient, Public, USC, STI, MPH, Point-of-care testing, FDA, Pharmaceutical industry

STONE HARBOR, N.J., March 13, 2024 /PRNewswire/ -- Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.

Key Points: 
  • STONE HARBOR, N.J., March 13, 2024 /PRNewswire/ -- Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.
  • Board members have expressed their enthusiasm for the impact they can have on the syphilis epidemic by working with Diagnostics Direct:
    Dr. Jeffrey Klausner remarked, "I am pleased to lead the Diagnostics Direct Medical Advisory Board.
  • Dr. Leandro Mena shared, "I am thrilled to join the Diagnostics Direct Medical Advisory Board, where our shared dedication to revolutionizing point-of-care testing and enhancing syphilis diagnostics is key.
  • The formation of the Medical Advisory Board by Diagnostics Direct signifies a major step forward in combating the spread of syphilis through innovative, accessible testing solutions.

Study Links Key Gene to Protection from Severe Illness and Death From Covid Infections in Men Under Age 75

Retrieved on: 
Wednesday, March 13, 2024
Inflammation, Gene, Brain, Letter, Internal medicine, Rheumatoid arthritis, COVID-19, NYU Langone Health, Infection, Disease, Abramson, Risk, Patient, APG system, Journal, Research, IL1, Factorization of polynomials, Canakinumab, NYU, Death, Doctor of Philosophy, SARS-CoV-2, Attur, Salem, Arthritis, Woman, Male, MPH, National Institutes of Health, IL1RN, Vasopressin receptor 2, Bangladesh Technical Education Board, Fatigue, Blood, Viral, Hospital, Pharmaceutical industry

NEW YORK, March 13, 2024 /PRNewswire/ -- A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows.

Key Points: 
  • NEW YORK, March 13, 2024 /PRNewswire/ -- A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows.
  • According to the study authors, the protective gene in question, an interleukin-1 receptor antagonist (IL1RN) variant, appears to tamp down inflammation.
  • Overall, more men than women (240 men, at 60.5%; and 157 women, at 39.5%) died from their disease, with women 20% less likely to die than men.
  • Funding support for this study was provided by National Institutes of Health grants P30CA016087 and R21AR078466.

Herzing University and Medical College of Wisconsin Forge Strategic Partnership to Launch Innovative 4+1 Program

Retrieved on: 
Wednesday, March 13, 2024
Transfer, Master, Postgraduate education, Medical College of Wisconsin, Public health, Partnership, Medical college, Public, MCW, Research, BSHS, University, Doctor of Philosophy, Faculty, Herzing University, Student, MPH, Curriculum, Criterion, GPA, School, Nursing

MILWAUKEE, March 13, 2024 /PRNewswire/ -- Herzing University and the Medical College of Wisconsin (MCW) are excited to announce a pioneering collaboration aimed at providing students with a streamlined route to obtain both undergraduate and graduate degrees in five years. The newly established 4+1 Program integrates Herzing University's Bachelor of Science in Health Sciences (BSHS) curriculum with MCW's renowned Master of Public Health (MPH) Program, offering direct admission to qualified BSHS students.

Key Points: 
  • The 4+1 Program is a five-year dual degree initiative designed to facilitate seamless transition for eligible Herzing University students into the Master of Public Health Program at MCW's School of Graduate Studies.
  • "At Herzing University, we're committed to providing innovative pathways for our students to excel in the ever-evolving healthcare landscape," said Dr. Sarah Olson, PhD, Program Chair – Healthcare Management/Healthcare Administration & Health Sciences, Herzing University.
  • "The Medical College of Wisconsin is excited to partner with Herzing University in launching the 4+1 Program, which represents a significant step forward in our joint efforts to cultivate the next generation of public health leaders," said Kim Contardi, MPH, MPH Program Manager, Medical College of Wisconsin.
  • The collaboration between Herzing University and the Medical College of Wisconsin represents a significant step forward in advancing healthcare education and preparing future leaders in public health.

Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board

Retrieved on: 
Tuesday, March 12, 2024
Exercise, Learning, Men's Health, Beauty, MSHS, Sports medicine, Hot, NFL, Physical, Research, Innovation, The New York Times, The Pew Charitable Trusts, Partnership, Private practice, Education, Harvard University, Mexico national football team, Policy, Bodybuilding.com, MLS, American College, Physical fitness, Medicine, Fatigue, Harvard Medical School, Metabolism, Longevity, Advisory board, Sport, Public, FACP, ACSM, Senior, Athlete, MPH, FACSM, LOS, DPT, Premiership Rugby, Physical activity, Doctor of Philosophy, Physical therapy, Quicksilver, CSCS, MLB, Johns Hopkins University, Red Bull, Osteoporosis, Bangladesh Technical Education Board, NBA, Physician

LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.

Key Points: 
  • In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
  • Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
  • Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
  • Therabody has completed 21 scientific studies to date with 26 currently in progress.

Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board

Retrieved on: 
Tuesday, March 12, 2024
Exercise, Learning, Men's Health, Beauty, MSHS, Sports medicine, Hot, NFL, Physical, Research, Innovation, The New York Times, The Pew Charitable Trusts, Partnership, Private practice, Education, Harvard University, Mexico national football team, Policy, Bodybuilding.com, MLS, American College, Physical fitness, Medicine, Fatigue, Harvard Medical School, Metabolism, Longevity, Advisory board, Sport, Public, FACP, ACSM, Senior, Athlete, MPH, FACSM, LOS, DPT, Premiership Rugby, Physical activity, Doctor of Philosophy, Physical therapy, Quicksilver, CSCS, MLB, Johns Hopkins University, Red Bull, Osteoporosis, Bangladesh Technical Education Board, NBA, Physician

LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.

Key Points: 
  • In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
  • Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
  • Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
  • Therabody has completed 21 scientific studies to date with 26 currently in progress.

High Prevalence of Cognitive Impairment in Patients with Heart Failure Shown to Negatively Impact Disease Self-Management

Retrieved on: 
Tuesday, March 12, 2024
Function (mathematics), JCF, Prevalence, Learning, Deficit spending, Disease, Cognitive deficit, Heart failure, Memory, Patient, University of Utah, Knowledge, Journal, University, HF, Life expectancy, Science, Heart, MPH, Social cognition, Diuretic, Language, Medical device

The Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement published today in the Journal of Cardiac Failure (JCF), indicates that clinicians have a responsibility to recognize and address cognitive impairment as an integral component of personalized care for patients with heart failure (HF).

Key Points: 
  • The Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement published today in the Journal of Cardiac Failure (JCF), indicates that clinicians have a responsibility to recognize and address cognitive impairment as an integral component of personalized care for patients with heart failure (HF).
  • Heart failure clinicians should be equipped with tools to assess and identify markers for cognitive impairment.
  • Cognitive Impairment in Heart Failure outlines several domains affected by cognitive impairment including learning and memory, executive function, complex attention, perceptual-motor function, language, and social cognition.
  • The Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement is available online in the JCF at www.onlinejcf.com .

Empowering 31,000 Lives Annually: Caminar's Impact Report Unveils Ongoing Commitment to Bay Area Mental Health Needs

Retrieved on: 
Tuesday, March 12, 2024
Mental health, San Francisco Giants, Curse of Coogan's Bluff, Science, Partnership, SAN, Employment, Child, Doctor of Philosophy, HEART, MBA, MPH, Senior counsel, Wellness, MPP, HUD, Contra Costa, Violence

SAN MATEO, Calif., March 12, 2024 /PRNewswire/ -- Caminar, a leading Bay Area behavioral health care agency, today released its annual Impact Report for the fiscal year 2022-2023. Over the last twelve months, Caminar's programs and services reached more than 31,000 youth, adults, and families across six Bay Area and Northern California counties through services that include counseling, addiction treatment, housing support, and education programs.

Key Points: 
  • SAN MATEO, Calif., March 12, 2024 /PRNewswire/ -- Caminar , a leading Bay Area behavioral health care agency, today released its annual Impact Report for the fiscal year 2022-2023.
  • Behavioral health needs continue to increase, with the Housing and Urban Development (HUD) reporting that among individuals experiencing housing insecurity, one of California's ongoing challenges, nearly 21% have a serious mental health condition .
  • "We are committed to delivering exceptional care to our clients, grounded in the highest standards of science and compassion.
  • Caminar events expand awareness of the growing mental health needs in the community by helping to destigmatize care access.

Industry Thought Leadership on Display at HIMSS24 Global Conference

Retrieved on: 
Monday, March 11, 2024
Automation, Conference, Health, Innovation, Revenue cycle management, RCM, HIMSS, MPH, FAAP, Exhibition, Becker, Emerging market, Pharmaceutical industry

ORLANDO, Fla., March 11, 2024 /PRNewswire/ -- FinThrive, Inc., a leading provider of healthcare revenue cycle management software solutions, announces participation in HIMSS24, the healthcare industry's premier event. Attendees can visit Booth #4851, where FinThrive will unveil its latest solutions, complemented by a live C-suite focused podcast, an education session to foster conversations with healthcare professionals, and in-booth demos and discussions.

Key Points: 
  • This data-driven framework is helping healthcare finance leaders benchmark and build strategic roadmaps to optimize and modernize their technology investments.
  • Becker and Clawson will share how RCMTAM is helping to shape transformative revenue cycle management strategies to improve financial performance.
  • Craig Joseph, MD, FAAP, FAMIA, Chief Medical Officer, Nordic Global, discussing where health IT is going beyond 2024, starting with the human connection.
  • To discover more about FinThrive Analyze and other solutions within the FinThrive end-to-end Revenue Cycle Management platform, visit Booth #4851 at the HIMSS24 Global Health Conference & Exhibition, March 11-15 in Orlando, Fla.
    For more information about FinThrive, visit https://finthrive.com .

New consortium of healthcare leaders announces formation of Trustworthy & Responsible AI Network (TRAIN), making safe and fair AI accessible to every healthcare organization

Retrieved on: 
Monday, March 11, 2024
Informatics, Algorithm, Responsibility, Information technology, Health, Biomedical Research, Patient, Cleveland Clinic, Approximation error, Artificial intelligence in healthcare, Microsoft, Public, AdventHealth, Mass General Brigham, Coalition, Science, Policy, Safety, Boston Children's Hospital, VUMC, Organization, Bias, Trust (social science), Research, AI, University, Nouvelle AI, MPH, Vanderbilt University Medical Center, Hospital, Sharp HealthCare, Internal medicine, Health informatics, Conference, Public health, Cardiology, Caregiver, MedStar Health, CHAI, HIMSS, Mount Sinai Health System, Medical device

New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.

Key Points: 
  • New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.
  • Enabling registration of AI used for clinical care or clinical operations through a secure online portal.
  • "By working together, TRAIN members aim to establish best practices for operationalizing responsible AI, helping improve patient outcomes and safety while fostering trust in healthcare AI."
  • "We are excited to join our TRAIN partners in the journey to accelerate AI innovation in an ethical, responsible and safe way."